| |
| |
|
| Insider
Information: |
Reardon William S |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
91,142 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,710,711 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
91,142 |
|
|
| Total
Value |
$13,710,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 8.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aceragen, Inc |
ACGN |
Director |
2017-07-03 |
32,973 |
2004-07-08 |
0 |
Premium* |
|
|
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
2,553 |
2004-12-13 |
0 |
Premium* |
|
|
Madrigal Pharmaceuticals Inc |
MDGL |
Director |
2015-07-01 |
49,392 |
|
0 |
Premium* |
|
|
Tekla Life Sciences Investors |
HQL |
Director |
2014-06-30 |
1,612 |
2012-03-09 |
0 |
Premium* |
|
|
H&Q Healthcare Investors |
HQH |
Director |
2014-06-24 |
1,470 |
2012-03-09 |
0 |
Premium* |
|
|
Tekla Healthcare Opportunities F... |
THQ |
Director |
2021-02-25 |
1,196 |
2021-02-25 |
0 |
Premium* |
|
|
Tekla World Healthcare Fund |
THW |
Director |
2021-04-06 |
1,946 |
2021-02-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2015-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,953 |
49,392 |
0 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2004-12-13 |
4 |
OE |
$0.38 |
$8,963 |
D/D |
13,219 |
13,219 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2006-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,400 |
15,619 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2007-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
2,253 |
0 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2008-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
2,553 |
0 |
- |
|
| THQ |
Tekla Healthcare Opportun... |
Director |
– • – |
2021-02-25 |
4 |
B |
$20.85 |
$24,937 |
D/D |
1,196 |
1,196 |
2.39 |
% |
|
| HQL |
Tekla Life Sciences Inves... |
Director |
– • – |
2012-03-09 |
4 |
B |
$13.27 |
$10,241 |
D/D |
772 |
772 |
2.39 |
- |
|
| HQL |
Tekla Life Sciences Inves... |
Director |
– • – |
2014-06-24 |
4 |
OE |
$19.75 |
$11,416 |
D/D |
578 |
1,412 |
0 |
- |
|
| HQL |
Tekla Life Sciences Inves... |
Director |
– • – |
2014-06-30 |
4 |
B |
$19.75 |
$3,950 |
D/D |
200 |
1,612 |
2.31 |
- |
|
| THW |
Tekla World Healthcare Fu... |
Director |
– • – |
2021-02-25 |
4 |
B |
$17.14 |
$25,024 |
D/D |
1,460 |
1,460 |
2.39 |
% |
|
| THW |
Tekla World Healthcare Fu... |
Director |
– • – |
2021-04-06 |
4 |
OE |
$14.26 |
$6,931 |
D/D |
486 |
1,946 |
0 |
- |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
